Immuno-Oncology

Immuno-Oncology Innovation Award

Miltenyi Biotec is excited to honor researchers around the globe for their contributions to the immuno-oncology field. Innovative research will be awarded with travel, accommodation, and registration to selected immuno-oncology meetings. In addition, the winner will have the opportunity to share his or her research with the scientific community.

Upcoming meetings:

American Society of Hematology (ASH) Annual Meeting & Exposition
December 01–04, 2018 | San Diego, California, USA

Abstract submission deadline: October 17, 2018
Travel award winner announcement: November 01, 2018

American Association for Cancer Research (AACR) Annual Meeting
March 30–April 03, 2019 | Atlanta, Georgia, USA

Abstract submission deadline: February 14, 2019
Travel award winner announcement: March 01, 2019

The 18th Meeting of the Society for Natural Immunity
September 30–October 03, 2019 | Luxembourg

Abstract submission deadline: August 16, 2019
Travel award winner announcement: September 01, 2019


This contest is open for participation, at no charge, according to the respective deadlines.
Simply fill out the form bellow to submit you abstract.


Winner Immuno-Oncology Innovation Award – American Association for Cancer Research (AACR) 
April 14–18, 2018 | Chicago, Illinois, USA

Brian Koss 
University of Arkansas for Medical Sciences, Biochemistry and Molecular Biology, United States
Epigenetic regulation of metabolic stress pathways in melanoma infiltrating lymphocytes

Winner Immuno-Oncology Innovation Award – The 17th Meeting of the Society for Natural Immunity
 
May 28–June 1, 2018 | San Antonio Texas, USA

Damya Laoui, Ph.D., Post-doctoral Scientist
Flanders Institute for Biotechnology, Vrije Universiteit Brussels, Brussels, Belgium
Lunch Symposium: Primary dendritic cells in cancer therapy

Winner Immuno-Oncology Innovation Award – 15th International Symposium on Dendritic Cells
 
June 10–14, 2018 | Aachen, Germany

Aurelien Colamartino
University of Montreal, CRCHU Sainte Justine, Montreal, Canada
Robust NK cells transduction technique opens new possibilities for cancer immunotherapy

Check out what the winners of our previous travel awards have to say: 

Constantine Bitsaktsis
Seton Hall University, South Orange


Winner of the
AAI Travel Award 2017

"My group has been using the MACSQuant® Flow Cytometer for our cancer peptide binding assays to identify the activation status of NK cells."

Constantine Bitsaktsis, Ph.D., is an Assistant Professor in the Department of Biological Sciences at Seton Hall University. He obtained his doctorate degree from King’s College University of London in 2002. He then moved state-side where he held two postdoctoral positions at the Wadsworth Center and the Albany Medical College in Albany, NY. His research is currently focusing on the utilization of novel vaccine approaches to combat microbial pathogens by generating long-term, protective immune responses.



Guobao Chen
John Hopkins University School of Medicine, Baltimore


Winner of the
AAI Travel Award 2017

"MACS® Microbeads for magnetic cell separation helped us to get 96.4% purity of a specific subset of cardiac fibroblasts out from the whole dissociated mouse heart cells."

Guobao Chen, Ph.D., is a Research Postdoctoral Fellow (Immunology Program), in the Department of Pathology at Johns Hopkins University School of Medicine. Dr. Chen received his doctoral degree in Immunology from National University of Singapore. His current project is focusing on the mechanism behind post-injury cardiac inflammation and remodeling.

Quirin Hammer
DRFZ, Berlin 


Winner of the
Immunology Travel Award 2016

"The Immunology Travel Award is a great opportunity for young scientists to participate in exciting scientific conferences. It shows Miltenyi Biotec's commitment to interaction within the field of immunology and is an excellent strategy to support early career immunologists.“

Quirin Hammer is currently a Ph.D. student in the Romagnani lab at the German Rheumatism-Research Center, Berlin. His general research interest lies in the field of regulation of innate lymphoid cell functions. His current research project focuses on natural killer (NK) cell memory during human cytomegalovirus (HCMV) infection.


Mélanie Durand
Institut Curie Research Center, Paris


Winner of the
Immunology Travel Award 2016

"The DC meeting 2016 was for me a unique opportunity in my Ph.D. to discuss with peers about my project but also about their project to have a larger view of the DC world. Thanks to Miltenyi Biotec's travel grant, I had a really amazing scientific time in Shanghai."

Mélanie Durand is currently a Ph.D. student in the Amigorena lab at the Institut Curie Research Center in Paris, France. Her research interest lies in the field of antigen presentation in dendritic cells and the molecular analysis of immune responses, particularly in the context of cancer.

Apply now – simply fill out the form bellow
We will process your personal data according to our privacy statement.